Clinical trials recruiting for Colo-rectal Cancer

Phase breakdown

Drugs and treatments being studied

Where trials are recruiting (top US states)

Top cities

Self-screener

Recruiting trials

• A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)
  NCT07058012 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 9 locations
• A Study of Biological, Genetic, and Constitutional Factors and Non-invasive Monitoring to Assess Personal Cancer Risks
  NCT07469709 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Adjuvant Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) in Resected High Risk Colon Cancer Patients
  NCT03280511 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Advanced Endo-therapeutic Procedure : Registry-based Observational Study
  NCT04117100 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Compare the Patient Satisfaction and Effectiveness After Novel Application-based or Conventional Health Education of Bowel Preparation for Colonoscopy
  NCT06560671 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Development of Organoids From Primary Colorectal Tumors and Synchronous Liver Metastases
  NCT06787625 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• EMVI as a Determinant of Metastasis in Colorectal Cancer
  NCT06646341 · Phase: Not specified · Ages: 16 Years to 100 Years · Sex: All (male and female) · 1 location
• Early-Onset Colorectal Cancer: An Observational Retrospective and Prospective Multicenter Study
  NCT06965335 · Phase: Not specified · Ages: 18 Years to 40 Years · Sex: All (male and female) · 1 location
• Effect of Synbiotic Supplementation on the Prevention of Mucositis in Cancer Patients Undergoing Chemotherapy
  NCT06576986 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Eliminating Barriers to Colorectal Cancer Screening Using Rapid Cycle Testing: A Pilot Study
  NCT05524428 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 4 locations
• Engineered TILs/CAR-TILs to Treat Advanced Solid Tumors
  NCT04842812 · Phase: Phase 1 · Ages: 18 Years to 85 Years · Sex: All (male and female) · 2 locations
• Evaluation of SINGLE PORT (SP) Robotic Technology in Colorectal Surgery
  NCT05321134 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Evaluation of the Natera Colorectal Cancer Screening Test in an Average Risk Population (FIND-CRC)
  NCT07046585 · Phase: Not specified · Ages: 40 Years and older · Sex: All (male and female) · 1 location
• Liquid Biopsy and Machine Learning for Early Colorectal Cancer, Adenomas, Lynch Cancers, and Residual Disease Detection
  NCT07450612 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 4 locations
• Low-dose Trifluridine/Tipiracil With Bevacizumab in mCRC
  NCT07085169 · Phase: Phase 2 · Ages: 60 Years and older · Sex: All (male and female) · 2 locations
• PRE-ISPY Phase I/II Oncology Platform Program
  NCT05868226 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 10 locations
• Performance of Spectral CT-scan in Patients With Metastatic Colorectal Cancer: a Prospective Multicentre Study
  NCT06024837 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 1 location
• Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
  NCT07145255 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 7 locations
• Phase Ⅱ Clinical Trial of Cadonilimab Combined With Anti-angiogenic Agents in Metastatic dMMR/MSI-H CRC
  NCT07003022 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Pre-therapeutic MRI Assessment of Early-Stage Rectal Cancer and Significant Rectal Polyps to Avoid Major Resectional Surgery
  NCT04103372 · Phase: Not applicable (e.g. observational or device study) · Ages: 16 Years to 100 Years · Sex: All (male and female) · 23 locations
• Shield Post-Approval Study Protocol
  NCT06880055 · Phase: Not specified · Ages: 45 Years to 81 Years · Sex: All (male and female) · 69 locations
• Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET Trial
  NCT06563388 · Phase: Phase 3 · Ages: 1 Year and older · Sex: All (male and female) · 2 locations
• The AIDPRO-CRC Trial
  NCT06645015 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 8 locations
• The Effect of the Training Program Given to Permanent Colostomy Patients on Self-efficacy
  NCT06905925 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 100 Years · Sex: All (male and female) · 1 location
• Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors
  NCT03755739 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• tislelizUMaB in canceR Patients With molEcuLar residuaL Disease
  NCT06332274 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Related conditions

Trials recruiting for Colo-rectal Cancer often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Colo-rectal Cancer trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.